Login / Signup

Regulatory authority and clinical acceptability: Physicians' responses to regulatory drug safety warnings.

Alice L BhasaleAmeet SarpatwariWendy LipworthMathias MøllebaekEliza J McEwinNileesa GautamAdrian Santiago OrtizBarbara J Mintzes
Published in: British journal of clinical pharmacology (2021)
Drug safety warnings may not be optimally received or used. Regulators should consider strategies that increase trust, clinical relevance and accessibility, and address physicians' needs in communicating risk to patients.
Keyphrases
  • primary care
  • transcription factor
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • healthcare
  • adverse drug